Atogepant
In Stock•Starting at $154 for 25 mg•Purity ≥ 98%
| CAS No. | 1374248-81-3 |
|---|---|
| MDL No. | N/A |
| MF | C29H23F6N5O3 |
| MW | 603.50 |
| InChI Key | QIVUCLWGARAQIO-OLIXTKCUSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 25 mg | 98% | $154 | In Stock | |
| 50 mg | 98% | $261 | In Stock | |
| 100 mg | 98% | $442 | In Stock | |
| 250 mg | 98% | $835 | In Stock | |
| 1 g | 98% | $2249 | In Stock |
Product Information
Atogepant is a secondary carboxamide formed by the condensation of the carboxy group of (3'S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid with the amino group of (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one. It is a selective oral, small-molecule CGRP receptor antagonist approved for migraine treatment. It is classified as a secondary carboxamide, azaspiro compound, organic heterotetracyclic compound, trifluorobenzene, and piperidone.
| CAS No. | 1374248-81-3 |
|---|---|
| Product Name | Atogepant |
Biological Targets
CALCRL
Associated Conditions
migraine disorder
* The information provided here is compiled from public sources and is for reference only.
